Literature DB >> 1730474

Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro.

B Wåhlin1, A Sjölander, N Ahlborg, R Udomsangpetch, A Scherf, D Mattei, K Berzins, P Perlmann.   

Abstract

Lines of Plasmodium falciparum FCR3 either expressing or not expressing the blood-stage antigen Pf155/RESA were used to analyze the possible involvement of this antigen in the merozoite invasion process in vitro. Antibodies from human sera, affinity purified on synthetic peptides corresponding to C-terminal repeated sequences in Pf155/RESA, were shown to inhibit merozoite invasion of both types of parasites with similar efficiency. Reversal of the invasion inhibition by fusion proteins containing repeated sequences of Pf155/RESA but not of the cross-reactive antigens Ag332 and Pf11.1 indicated that the inhibitory antibodies had similar target antigens in both Pf155/RESA+ and Pf155/RESA- parasites that involved cross-reacting epitopes present in Pf155/RESA. Rabbit antibodies specific for Pf155/RESA repeats inhibited merozoite invasion of Pf155/RESA expressing parasites efficiently but had no or very small effect on the invasion of Pf155/RESA-deficient parasites. In contrast, rabbit antibodies specific for Ag332 repeats as well as human antibodies affinity purified on synthetic Ag332 peptides inhibited merozoite invasion of both types of parasites with high efficiency. A similar inhibition pattern was seen with the human monoclonal antibody 33G2, which has specificity for Ag332 but also cross-reacts with Pf155/RESA and Pf11.1. Taken together, our data suggest that Pf155/RESA and related cross-reactive antigens as well as Ag332 are involved in the merozoite invasion process and may constitute targets for invasion inhibitory antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730474      PMCID: PMC257647          DOI: 10.1128/iai.60.2.443-449.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  A general strategy for polymerization, assembly and expression of epitope-carrying peptides applied to the Plasmodium falciparum antigen Pf155/RESA.

Authors:  S Ståhl; A Sjölander; M Hansson; P A Nygren; M Uhlén
Journal:  Gene       Date:  1990-05-14       Impact factor: 3.688

2.  A and T homopolymeric stretches mediate a DNA inversion in Plasmodium falciparum which results in loss of gene expression.

Authors:  L G Pologe; D de Bruin; J V Ravetch
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 3.  Solid-phase peptide synthesis.

Authors:  R B Merrifield
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

4.  Immunization, isolation of immunoglobulins, estimation of antibody titre.

Authors:  N Harboe; A Ingild
Journal:  Scand J Immunol Suppl       Date:  1973

5.  Plasmodium falciparum: differential parasite reactivity of rabbit antibodies to repeated sequences in the antigen Pf155/RESA.

Authors:  J Carlsson; R Udomsangpetch; B Wåhlin; N Ahlborg; K Berzins; P Perlmann
Journal:  Exp Parasitol       Date:  1990-10       Impact factor: 2.011

6.  Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2.

Authors:  N Ahlborg; K Berzins; P Perlmann
Journal:  Mol Biochem Parasitol       Date:  1991-05       Impact factor: 1.759

7.  Immunogenicity and antigenicity in rabbits of a repeated sequence of Plasmodium falciparum antigen Pf155/RESA fused to two immunoglobulin G-binding domains of staphylococcal protein A.

Authors:  A Sjölander; S Ståhl; P A Nygren; L Aslund; N Ahlborg; B Wåhlin; A Scherf; K Berzins; M Uhlén; P Perlmann
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

8.  Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences.

Authors:  R L Coppel; A F Cowman; R F Anders; A E Bianco; R B Saint; K R Lingelbach; D J Kemp; G V Brown
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

9.  Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum.

Authors:  R Udomsangpetch; K Lundgren; K Berzins; B Wåhlin; H Perlmann; M Troye-Blomberg; J Carlsson; M Wahlgren; P Perlmann; A Björkman
Journal:  Science       Date:  1986-01-03       Impact factor: 47.728

10.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  12 in total

1.  Isolation of peptides that mimic epitopes on a malarial antigen from random peptide libraries displayed on phage.

Authors:  C G Adda; L Tilley; R F Anders; M Foley
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.

Authors:  N Ahlborg; R Andersson; P Perlmann; K Berzins
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

3.  Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas.

Authors:  A B Siddique; N Ahlborg; M Warsame; P Perlmann; K Berzins
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.

Authors:  S K Joshi; A Bharadwaj; S Chatterjee; V S Chauhan
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

5.  Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.

Authors:  J Iqbal; P Perlmann; B M Greenwood; K Berzins
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

Authors:  Preeyaporn Monatrakul; Mathirut Mungthin; Arjen M Dondorp; Srivicha Krudsood; Rachanee Udomsangpetch; Polrat Wilairatana; Nicholas J White; Kesinee Chotivanich
Journal:  Malar J       Date:  2010-11-16       Impact factor: 2.979

7.  Possible association of the Plasmodium falciparum T1526C resa2 gene mutation with severe malaria.

Authors:  Rémy Durand; Florence Migot-Nabias; Valérie Andriantsoanirina; Elise Seringe; Firmine Viwami; Gratien Sagbo; Francis Lalya; Philippe Deloron; Odile Mercereau-Puijalon; Serge Bonnefoy
Journal:  Malar J       Date:  2012-04-25       Impact factor: 2.979

8.  Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria.

Authors:  Cyril Badaut; Léa Guyonnet; Jacqueline Milet; Emmanuelle Renard; Rémy Durand; Firmine Viwami; Gratien Sagbo; Francis Layla; Philippe Deloron; Serge Bonnefoy; Florence Migot-Nabias
Journal:  Malar J       Date:  2015-07-16       Impact factor: 2.979

9.  A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion.

Authors:  Kirsten Moll; Arnaud Chêne; Ulf Ribacke; Osamu Kaneko; Sandra Nilsson; Gerhard Winter; Malin Haeggström; Weiqing Pan; Klavs Berzins; Mats Wahlgren; Qijun Chen
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

10.  Benchmarking B-cell epitope prediction with quantitative dose-response data on antipeptide antibodies: towards novel pharmaceutical product development.

Authors:  Salvador Eugenio C Caoili
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.